Publications

 

 

Sevoflurane for Sedation in ARDS: A Randomized Controlled Pilot Study. Jabaudon M, Boucher P, Imhoff E, Chabanne R, Faure JS, Roszyk L, Thibault S, Blondonnet R, Clairefond G, Guérin R, Perbet S, Cayot S, Godet T, Pereira B, Sapin V, Bazin JE, Futier E, Constantin JM. Am J Respir Crit Care Med. 2017 Mar 15;195(6):792-800. doi: 10.1164/rccm.201604-0686OC.

Elevated Plasma Levels of sRAGE are Associated with Non-Focal CT-Based Lung Imaging in ARDS patients: A Prospective Multicenter Study.

Mrozek S, Jabaudon M, Jaber S, Paugam-Burtz C, Lefrant JY, Rouby JJ, Asehnoune K, Allaouchiche B, Baldesi O, Leone M, Lu Q, Bazin JE, Roszyk L, Sapin V, Futier E, Pereira B, Constantin JM; Azurea network. Chest. 2016 Mar 23. pii: S0012-3692(16)45713-2. doi: 10.1016/j.chest.2016.03.016.

A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome. Blondonnet R, Constantin JM, Sapin V, Jabaudon M. Dis Markers. 2016;2016:3501373. doi: 10.1155/2016/3501373.

Net alveolar fluid clearance is associated with lung morphology phenotypes in acute respiratory distress syndrome. Jabaudon M, Blondonnet R, Lutz J, Roszyk L, Bouvier D, Guérin R, Perbet S, Cayot S, Godet T, Blanchon L, Bazin JE, Futier E, Sapin V, Constantin JM. Anaesth Crit Care Pain Med 2016 Feb 26. pii: S2352-5568(16)00026-6. doi: 10.1016/j.accpm.2015.11.006. [Epub ahead of print]

 

 

Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: an observational prospective study. Jabaudon M, Blondonnet R, Roszyk L, Pereira B, Guérin R, Perbet S, Cayot S, Bouvier D, Blanchon L, Sapin V, Constantin JM. PLoS One 2015 Aug 14;10(8):e0135857. doi: 10.1371/journal.pone.0135857.

 

 

Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome. Jabaudon M, Blondonnet R, Roszyk L, Bouvier D, Audard J, Clairefond G, Fournier M, Marceau G, Déchelotte P, Pereira B, Sapin V, Constantin JM. Am J Respir Crit Care Med 2015 Jul 15;192(2):191-9. doi: 10.1164/rccm.201501-0020OC.

 

 

Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury. Jabaudon M, Futier E, Roszyk L, Sapin V, Pereira B, Constantin JM. Respirology 2015 jun 29. doi:10.1111/resp.12583.

 

 

 

Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Jabaudon M, Hamroun N, Roszyk L, Guérin R, Bazin JE, Sapin V, Pereira B, Constantin JM. Intensive Care Med 2015 May;41(5):846-55. doi: 10.1007/s00134-015-3726-0.

 

 

Plasma levels of sRAGE, loss of aeration and weaning failure in ICU patients: a prospective observational multicenter study. Jabaudon M, Perbet S, Pereira B, Soummer A, Roszyk L, Guérin R, Futier E, Lu Q, Bazin JE, Sapin V, Rouby JJ, Constantin JM. PLoS One 2013 May 27;8(5):e64083. doi: 10.1371/journal.pone.0064083.

 

 

Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Jabaudon M, Futier E, Roszyk L, Chalus E, Guérin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier C, Sapin V, Bazin JE, Constantin JM. Crit Care Med 2011 Mar;39(4):480-8. doi:10.1097/CCM.0b013e318206b3ca.